North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Recent Updates - Updated items
All Formulary Amendments
Records 31 to 46 of 46
New
Newer
Details
UPD
Venetoclax NICE TA765. APC - April 2022
26/04/2022 12:03:04
(DavidS )
UPD
NHSE Changed from N
26/04/2022 11:35:59
(DavidS )
UPD
sitematrix Changed from 0 to
26/04/2022 11:35:59
(DavidS )
UPD
isHC Changed from N to Y
26/04/2022 11:35:59
(DavidS )
UPD
isCyto Changed from 0 to 1
26/04/2022 11:35:59
(DavidS )
UPD
FurtherInformation Changed from
Approved for the treatment of adult patients with chronic lymphocytic leukaemia (CLL) in the presence of 17p deletion or TP53 mutations, and who are unsuitable for or have failed a B-cell receptor pat
26/04/2022 11:35:59
(DavidS )
UPD
Venetoclax updated
26/04/2022 11:35:59
(DavidS )
UPD
Venetoclax formatting updated
19/05/2021 16:47:23
(DavidS )
UPD
Venetoclax updated
26/02/2021 11:17:05
(DavidS )
UPD
Venetoclax NICE TA663
26/02/2021 11:16:38
(DavidS )
LDL
Link Added : NICE TA561: Venetoclax with rituximab for previously treated chronic lymphocytic leukaemia : https://www.nice.org.uk/guidance/ta561
25/04/2019 13:06:28
(DavidS )
UPD
Venetoclax updated NICE TA 561
25/04/2019 13:05:00
(DavidS )
UPD
Venetoclax b
01/02/2017 14:49:52
(DavidS )
UPD
Venetoclax b
23/01/2017 15:03:32
(WhitehallJ )
LDL
Link Added : Early Access to Medicines Scientific Opinion - Public Assessment Report : https://www.gov.uk/government/uploads/system/uploads/attachment data/file/547406/EAMS Public Assessment Report - Venetoclax.pdf
23/01/2017 15:03:15
(WhitehallJ )
ADD
Venetoclax b
23/01/2017 15:02:04
(WhitehallJ )